Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.2603
+0.0003 (0.12%)
At close: Jul 13, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $471.2 thousand as of July 20, 2026. Its market cap has decreased by -85.30% in one year.
Market Cap
471.20K
Enterprise Value
2.25M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.26
ChartMarket Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 471.20K, a decrease of -95.11%. That is a compound annual growth rate of -92.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 471.20K | -81.27% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Burzynski Research Institute | 761.09K |
| SQZ Biotechnologies Company | 707.79K |
| Windtree Therapeutics | 592.04K |
| Sorrento Therapeutics | 543.71K |
| Halberd | 523.11K |
| CERo Therapeutics Holdings | 520.44K |
| THC Farmaceuticals | 435.16K |
| Helix BioMedix | 402.23K |